Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Subjects Had Unipolar, Non-psychotic Major Depression
Interventions
DRUG

Risperidone

Risperidone will commence at 0.5 mg per day in a single daily dose given once in the evening. Clinicians will have the option, at each visit of increasing the risperidone dose to a maximum of 3 mg/day based on subject response and tolerability (please see Titration Recommendations below).

DRUG

Olanzapine

Olanzapine will commence at 2.5 mg per day in a single daily dose given once in the evening. Clinicians will have the option, at each visit, of increasing the olanzapine dose to a maximum of 15 mg/day based on subject response and tolerability.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT01282632 - Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression | Biotech Hunter | Biotech Hunter